🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 clinical trial is a double blind, placebo-controlled, randomiz...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-10
Trial ID
NCT01940315
Treatments Being Tested
The investigational product Baiya SARS-CoV-2 Vax 2 vaccine is a second-gene...
Status
Unknown
Location
Queen Saovabha Memorial Institute
Start Date
2023-12
Trial ID
NCT05873374
Treatments Being Tested
The purpose of the study is to demonstrate the safety and immunogenicity of...
Status
Completed
Location
Clinical Research Associates of Tidewater
Start Date
2009-09
Trial ID
NCT00985426
Treatments Being Tested
A Phase 2b Study to Determine the Efficacy of Candidate Influenza Vaccine M...
Status
Terminated
Location
Paratus Clinical Pty Ltd
Start Date
2019-03-18
Trial ID
NCT03880474
This is a randomized, double-blind, placebo-controlled study. Eligible subj...
Status
Completed
Location
Royal Liverpool University Hospital, Liverpool School of Tropical Medicine
Start Date
2014-09
Trial ID
NCT02116998
Treatments Being Tested
The purpose of this study is to test the safety and immunogenicity of MVA-B...
Status
Completed
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02376400
Treatments Being Tested
This Phase 3 study evaluates the safety, immunogenicity and lot-to lot cons...
Status
Completed
Location
Optimal Research, LLC
Start Date
2016-07-11
Trial ID
NCT02839330
This study evaluated the safety, tolerability, and efficacy of the cytomega...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0025)
Start Date
2018-04-30
Trial ID
NCT03486834
This study evaluates the reduction in viral shedding after vaccination with...
Status
Completed
Location
University of Alabama-Birmingham
Start Date
2015-11
Trial ID
NCT02515175
The purpose of this study is to evaluate the safety and immune response to ...
Status
Completed
Location
Aurum Tembisa CRS
Start Date
2016-06-21
Trial ID
NCT02997969
Treatments Being Tested